No advantage of “A β 42 -lowering” NSAIDs for prevention of AD in six pooled cohort studies
暂无分享,去创建一个
K. Welsh-Bohmer | M. Ganguli | L. Kuller | Truls Østbye | J. Breitner | B. Psaty | P. Wolf | A. Beiser | C. Kawas | R. Green | H. Dodge | S. Resnick | P. Zandi | C. Szekely | M. Corrada | MD DrPH | Ab | Zonderman | B. Psaty | M. Drph